Content
02/02/2021
New York, NY USA
Capital Rx
completed $50 million Series B Round funding. Investors include
Transformation Capital (lead), Edison Partners.
About
Capital Rx is a healthcare technology company advancing our nation’s electronic healthcare infrastructure to improve drug price visibility and patient outcomes. As a Certified B Corp™, the company is executing its mission through the deployment of JUDI®, Capital Rx’s cloud-native enterprise health platform, and an efficient Single-Ledger Model™, which increases visibility and reduces variability in drug prices. JUDI connects every aspect of the pharmacy ecosystem in one platform, servicing over 2.4 million members for Medicare, Medicaid, and commercial plans. Together with its clients, Capital Rx is reimagining the administration of pharmacy benefits and rebuilding trust in healthcare.
Startup
Sector:
Digital Health
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
